Feasibility study of a multimodal prehabilitation programme in women receiving neoadjuvant therapy for breast cancer in a major cancer hospital: a protocol

Introduction Neoadjuvant therapy has become a standard treatment for patients with stage II/III HER2 positive and triple negative breast cancer, and in well-selected patients with locally advanced and borderline resectable high risk, luminal B breast cancer. Side effects of neoadjuvant therapy, such...

Full description

Saved in:
Bibliographic Details
Main Authors: Sanjeev Kumar, María González, Judith Lacey, Cindy Mak, Gillian Heller, Suzanne J Grant, Shelley Kay, Kim Kerin-Ayres, Justine Stehn, Sandra Templeton, Jane Cockburn, Sara Wahlroos, Ashanya Malalasekera, Susannah Graham
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/3/e080239.full
Tags: Add Tag
No Tags, Be the first to tag this record!